FIELD: medicine, experimental cardiology. SUBSTANCE: method involves the combined administration of captopril and N-[2-(mercaptomethyl)-1-oxo-3-phenylpropyl] -$$$-alanine at doses 10-100 and 10 mcmole/kg body mass, respectively. Preparations were administrated simultaneously or at 4 h interval. EFFECT: improved method of treatment.
Authors
Dates
1997-05-27—Published
1992-08-11—Filed